| A trial of early antiretrovirals and isoniazid preventive therapy in Africa Temprano ANRS 12136 Study Group New England Journal of Medicine 373 (9), 808-822, 2015 | 1444 | 2015 |
| Working from home in the time of COVID-19: how to best preserve occupational health? H Bouziri, DRM Smith, A Descatha, W Dab, K Jean Occupational and environmental medicine 77 (7), 509-510, 2020 | 376 | 2020 |
| Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial A Badje, R Moh, D Gabillard, C Guéhi, M Kabran, JB Ntakpé, J Le Carrou, ... The Lancet global health 5 (11), e1080-e1089, 2017 | 198 | 2017 |
| Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study X Li, C Mukandavire, ZM Cucunubá, SE Londono, K Abbas, HE Clapham, ... The Lancet 397 (10272), 398-408, 2021 | 192 | 2021 |
| Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C‐infected Egyptian cohort: a comparative analysis M El Kassas, AL Funk, M Salaheldin, Y Shimakawa, M Eltabbakh, K Jean, ... Journal of viral hepatitis 25 (6), 623-630, 2018 | 92 | 2018 |
| The global burden of yellow fever KAM Gaythorpe, A Hamlet, K Jean, D Garkauskas Ramos, L Cibrelus, ... Elife 10, e64670, 2021 | 84 | 2021 |
| The seasonal influence of climate and environment on yellow fever transmission across Africa A Hamlet, K Jean, W Perea, S Yactayo, J Biey, M Van Kerkhove, ... PLoS neglected tropical diseases 12 (3), e0006284, 2018 | 84 | 2018 |
| The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries AY Chang, C Riumallo-Herl, NA Perales, S Clark, A Clark, D Constenla, ... Health Affairs 37 (2), 316-324, 2018 | 82 | 2018 |
| Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ... Gut 71 (3), 593-604, 2022 | 77 | 2022 |
| Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world J Toor, S Echeverria-Londono, X Li, K Abbas, ED Carter, HE Clapham, ... Elife 10, e67635, 2021 | 70 | 2021 |
| Uptake of HIV testing in Burkina Faso: an assessment of individual and community-level determinants F Kirakoya-Samadoulougou, K Jean, M Maheu-Giroux BMC public health 17, 1-11, 2017 | 66 | 2017 |
| Barriers to HIV testing in Côte d'Ivoire: the role of individual characteristics and testing modalities K Jean, X Anglaret, R Moh, F Lert, R Dray-Spira PLoS One 7 (7), e41353, 2012 | 65 | 2012 |
| Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Cote d'Ivoire K Jean, D Gabillard, R Moh, C Danel, R Fassassi, A Desgrées-du-Loû, ... The Journal of infectious diseases 209 (3), 431-440, 2014 | 56 | 2014 |
| A meta-analysis of serological response associated with yellow fever vaccination K Jean, CA Donnelly, NM Ferguson, T Garske The American journal of tropical medicine and hygiene 95 (6), 1435-1439, 2016 | 38 | 2016 |
| Temporal trends in socioeconomic inequalities in HIV testing: an analysis of cross-sectional surveys from 16 sub-Saharan African countries PA Ante-Testard, T Benmarhnia, A Bekelynck, R Baggaley, E Ouattara, ... The Lancet global health 8 (6), e808-e818, 2020 | 31 | 2020 |
| Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d’Ivoire, Mali and Senegal N Rouveau, O Ky-Zerbo, S Boye, AS Fotso, M d’Elbée, M Maheu-Giroux, ... BMC Public Health 21, 1-14, 2021 | 23 | 2021 |
| Eliminating yellow fever epidemics in Africa: vaccine demand forecast and impact modelling K Jean, A Hamlet, J Benzler, L Cibrelus, KAM Gaythorpe, A Sall, ... PLoS neglected tropical diseases 14 (5), e0008304, 2020 | 22 | 2020 |
| Association between Conflict and Cholera in Nigeria and the Democratic Republic of the Congo GEC Charnley, K Jean, I Kelman, KAM Gaythorpe, KA Murray Emerging infectious diseases 28 (12), 2472, 2022 | 19 | 2022 |
| Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk DRM Smith, A Duval, JR Zahar, ... Nature communications 13 (1), 236, 2022 | 19 | 2022 |
| How can the public health impact of vaccination be estimated? S Echeverria-Londono, X Li, J Toor, MJ de Villiers, S Nayagam, TB Hallett, ... BMC Public Health 21, 1-12, 2021 | 19 | 2021 |
Alexis DescathaPU-PH, Univ Angers, Inserm, Hofstra/ NorthwellAdresse e-mail validée de inserm.fr
